CAS: 1260907-17-2 - GSK525762
Formula:C22H22ClN5O2
InChI:InChI=1S/C22H22ClN5O2/c1-4-24-20(29)12-18-22-27-26-13(2)28(22)19-10-9-16(30-3)11-17(19)21(25-18)14-5-7-15(23)8-6-14/h5-11,18H,4,12H2,1-3H3,(H,24,29)/t18-/m0/s1
InChI key:InChIKey=AAAQFGUYHFJNHI-SFHVURJKSA-N
SMILES:O=C(NCC)CC1N=C(C=2C=CC(Cl)=CC2)C=3C=C(OC)C=CC3N4C(=NN=C41)C
4H-[1,2,4]Triazolo[4,3-a][1,4]benzodiazepine-4-acetamide, 6-(4-chlorophenyl)-N-ethyl-8-methoxy-1-methyl-, (4S)-
CAS:1260907-17-2
Formula:
C22H22ClN5O2
Purity:
98+%
Color and Shape:
Solid
Molecular weight:
423.8954
Ref: AN-AG000RLX
5mg | 50.00 € | |
10mg | 65.00 € | |
50mg | 172.00 € |
Estimated delivery in United States, on Friday 10 May 2024
Molibresib
CAS:1260907-17-2
Molibresib (GSK525762) is an inhibitor of BET proteins (IC50: about 35 nM).
Formula:
C22H22ClN5O2
Purity:
99.08%
Color and Shape:
Solid
Molecular weight:
423.9
Ref: TM-T1906
1mg | 42.00 € | |
2mg | 56.00 € | |
5mg | 91.00 € | |
10mg | 122.00 € | |
25mg | 213.00 € | |
50mg | 352.00 € | |
100mg | 526.00 € | |
200mg | 736.00 € | |
500mg | 1,149.00 € | |
1ml*10 (DMSO) | 91.00 € |
Estimated delivery in United States, on Friday 17 May 2024
Ref: 7W-GW4589
1mg | 218.00 € | |
5mg | 312.00 € | |
10mg | 406.00 € |
Estimated delivery in United States, on Friday 17 May 2024
GSK 525762A
Controlled ProductCAS:1260907-17-2
Applications GSK 525762A, is a BET Bromodomain Inhibitor, which is now in clinical development. BET …
Formula:
C22H22ClN5O2
Color and Shape:
Pale Yellow Solid
Molecular weight:
423.9
Ref: TR-G797505
5mg | 152.00 € | |
10mg | 268.00 € | |
25mg | 612.00 € |
Estimated delivery in United States, on Thursday 20 Jun 2024
Ref: TR-G797507
100mg | 15,186.00 € |
Estimated delivery in United States, on Thursday 20 Jun 2024
I-BET 762
Controlled ProductCAS:1260907-17-2
Inhibitor of BET bromodomain
Formula:
C22H22ClN5O2
Purity:
Min. 95%
Molecular weight:
423.9 g/mol
Ref: 3D-FG137683
10mg | To inquire | |
50mg | To inquire | |
3500mg | To inquire |
Estimated delivery in United States, on Friday 21 Jun 2024